Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 9.294% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CN(CCCC(=O)NC1CC(C)(C)NC(C)(C)C1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1
b.) Cc1cccc(NC(=O)c2nc[nH]c2C(=O)N[C@H](C)c2ccccc2)c1
c.) CCCNC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
Answer: c. CCCNC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
CCCNC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
N-propyl-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide